These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 11356947

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. D2 dopamine receptor-induced sensitization of adenylyl cyclase type 1 is G alpha(s) independent.
    Vortherms TA, Nguyen CH, Bastepe M, Jüppner H, Watts VJ.
    Neuropharmacology; 2006 Apr; 50(5):576-84. PubMed ID: 16376953
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation.
    Vortherms TA, Watts VJ.
    J Pharmacol Exp Ther; 2004 Jan; 308(1):221-7. PubMed ID: 14566008
    [Abstract] [Full Text] [Related]

  • 10. Heterologous sensitization of adenylate cyclase is protein kinase A-dependent in Cath.a differentiated (CAD)-D2L cells.
    Johnston CA, Beazely MA, Vancura AF, Wang JK, Watts VJ.
    J Neurochem; 2002 Sep; 82(5):1087-96. PubMed ID: 12358756
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.
    Watts VJ, Neve KA.
    Mol Pharmacol; 1996 Oct; 50(4):966-76. PubMed ID: 8863843
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adrenergic agonists induce heterologous sensitization of adenylate cyclase in NS20Y-D(2L) cells.
    Johnston CA, Cumbay MG, Vortherms TA, Watts VJ.
    FEBS Lett; 2001 May 25; 497(2-3):85-9. PubMed ID: 11377418
    [Abstract] [Full Text] [Related]

  • 16. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
    Gazi L, Bobirnac I, Danzeisen M, Schüpbach E, Bruinvels AT, Geisse S, Sommer B, Hoyer D, Tricklebank M, Schoeffter P.
    Br J Pharmacol; 1998 Jul 25; 124(5):889-96. PubMed ID: 9692773
    [Abstract] [Full Text] [Related]

  • 17. Protein kinase C and epidermal growth factor stimulation of Raf1 potentiates adenylyl cyclase type 6 activation in intact cells.
    Beazely MA, Alan JK, Watts VJ.
    Mol Pharmacol; 2005 Jan 25; 67(1):250-9. PubMed ID: 15470083
    [Abstract] [Full Text] [Related]

  • 18. Heterodimers of adenylyl cyclases 2 and 5 show enhanced functional responses in the presence of Galpha s.
    Baragli A, Grieco ML, Trieu P, Villeneuve LR, Hébert TE.
    Cell Signal; 2008 Mar 25; 20(3):480-92. PubMed ID: 18164588
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D2 receptor-induced heterologous sensitization of adenylyl cyclase requires Galphas: characterization of Galphas-insensitive mutants of adenylyl cyclase V.
    Watts VJ, Taussig R, Neve RL, Neve KA.
    Mol Pharmacol; 2001 Dec 25; 60(6):1168-72. PubMed ID: 11723222
    [Abstract] [Full Text] [Related]

  • 20. Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
    Barovsky K, Pedone C, Brooker G.
    Mol Pharmacol; 1984 Mar 25; 25(2):256-60. PubMed ID: 6321948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.